Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Candiolo
Clinical trial register · Italy

Clinical Trials in Candiolo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione del Piemonte per l'Oncologia17 AstraZeneca10 Italian Sarcoma Group8 Fondazione Italiana Linfomi - ETS8 Bristol-Myers Squibb6
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Candiolo

158 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Not yet open
Bristol-Myers Squibb
Phase 3
850
Meldola, Candiolo, Bergamo, Brescia, Milan, Pavia, Verona
2026-09-30
Recruiting
CSL Behring
Phase 3
63
Rome, Brescia, Varese, Candiolo, Catania, Florence, Milan
2026-09-15
Recruiting
Kyowa Kirin, Inc.
Phase 1
72
Candiolo, Bergamo, Bologna, Torino
2026-09-02
Not yet open
BV-CHP Real-life and Biological Evidences in Patients With sALCL
NCT07467317Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Avellino, Aviano, Bari, Bergamo, Bologna, Candiolo, Legnano, Milan
2026-09
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
518
Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania
2026-07-10
Recruiting
Novartis Pharmaceuticals
Phase 1
24
Candiolo
2026-06-12
Recruiting
Takeda
Phase 3
300
Florence, Rozzano, Pavia, Roma, Candiolo, Bologna, Milan, Naples
2026-05-21
Recruiting
Novartis Pharmaceuticals
Phase 1
24
Milan, Candiolo
2026-05-19
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Campania, Candiolo, Milan, Roma
2026-05-03
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Recruiting
Incyte Corporation
Phase 3
588
Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma
2026-04-09
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
118
Candiolo, Meldola, Ravenna
2026-03-31
Recruiting
Bristol-Myers Squibb
Phase 3
750
Ferrara (Cona), Aviano, Catania, Candiolo, Genova, Milan, Naples, Novara
2026-03-12
Recruiting
Incyte Corporation
Phase 3
700
Ancona, Aviano, Bari, Brescia, Candiolo, Catania, Milan, Naples
2026-03-05
Recruiting
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NCT07479277Non-Small Cell Lung Cancer, Postoperative Air Leak, NSCLC
Fondazione del Piemonte per l'Oncologia
Not applicable
160
Candiolo, Bolzano, Florence, Milan, Palermo, Pisa
2026-02-27
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07335497Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc.
Phase 1/2
290
Milan, Candiolo
2026-02-17
Recruiting
Genmab
Phase 2
240
Candiolo, Meldola, Orbassano, Ravenna, Roma
2026-01-30
Recruiting
AbbVie
Phase 2/3
490
Milan, Monza, Fano, Aviano, Rome, Candiolo, Catania, Verona
2025-12-10
Recruiting
GlaxoSmithKline
Phase 3
450
Meldola, Rozzano MI, Bari, Bologna, Candiolo, Genova, Milan, Padova
2025-12-03
Recruiting
Janssen Research & Development, LLC
Observational
380
Avellino, Aviano, Bari, Bergamo, Brescia, Candiolo, Catania, Catanzaro
2025-12-03
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Ancona, Candiolo, Meldola, Ravenna, Roma, Verona
2025-11-30
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Monza, Pesaro, Alessandria, Bergamo, Bologna, Brescia, Candiolo, Florence
2025-11-25
Recruiting
Italian Sarcoma Group
Phase 2
20
Candiolo, Milan, Padova, Prato, Roma
2025-11-21
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ravenna, Aviano, Orbassano, Candiolo, Avellino, Milan, Naples, Parma
2025-11-05
Recruiting
Daiichi Sankyo
Phase 3
686
Bologna, Candiolo, Fano, Genova, Livorno, Milan, Misterbianco, Orbassano
2025-10-24
Recruiting
Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients
NCT07514754Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Lung Cancer
Fondazione del Piemonte per l'Oncologia
Not applicable
52
Candiolo
2025-10-03
Recruiting
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Phase 4
50
Meldola, Candiolo, Bologna, Milan, Naples, Roma
2025-09-17
Recruiting
MIMICC Study in Patients With Colorectal Cancer
NCT07494201Colorectal Cancer, Colon Cancer, Rectal Cancers
Fondazione del Piemonte per l'Oncologia
Not applicable
2,500
Candiolo
2025-09-15
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Ancona, Brescia, Candiolo, Cona, Florence, Livorno, Meldola, Milan
2025-08-26
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
30
Candiolo
2025-07-03
Recruiting
Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer
NCT07507890Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast Cancer
Fondazione del Piemonte per l'Oncologia
Not applicable
10
Candiolo
2025-06-11
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
200
Candiolo, Florence, Milan, Padova, Palermo, Rome
2025-05-27
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bergamo, Bologna, Brescia, Candiolo, Cremona, Florence, Meldola, Milan
2025-05-22
Recruiting
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS
Observational
200
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche
2025-05-05
Recruiting
BioNTech SE
Phase 1/2
594
Candiolo, Milan, Naples, Roma, Verona
2025-05-02
Recruiting
AstraZeneca
Phase 3
830
Candiolo, Lecco, Lucca, Meldola, Milan, Naples, Peschiera del Garda, Pisa
2025-04-10
Recruiting
Gilead Sciences
Phase 3
695
Aviano, Candiolo, Lucca, Milan, Naples, Pesaro, Peschiera del Garda, Roma
2025-04-04
Active, closed
Immutep S.A.S.
Phase 3
756
Avellino, Aviano, Candiolo, Milan, Naples, Perugia, Reggio Emilia, Terni
2025-03-21
Recruiting
Fondazione del Piemonte per l'Oncologia
Observational
250
Candiolo
2025-02-19
By invitation
Prostate Cancer Screening: a Pilot Study
NCT06238661Prostate Cancer
Fondazione del Piemonte per l'Oncologia
Not applicable
4,500
Candiolo
2025-02-17
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Aviano, Milan, Candiolo, Florence, Roma
2025-02-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Monza, Rionero in Vulture, Palermo, Candiolo, Ancona, Brescia, Milan, Novara
2025-01-27
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
300
Candiolo, Pavia
2025-01-23
Recruiting
BioNTech SE
Phase 2/3
1,580
Avellino, Aviano, Bologna, Candiolo, Catania, Cona, Cremona, Lucca
2025-01-07
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Candiolo, Catania, Florence, Milan, Padova, Pisa, Rozzano, Udine
2024-12-12
Active, closed
Genmab
Phase 3
191
Monza, Rozzano, Naples, Aviano, Rome, Orbassano, Bergamo, Candiolo
2024-11-25
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Candiolo, Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Milan
2024-10-23
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Rome, Candiolo, Palermo, Bologna, Milan
2024-10-09
Recruiting
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
NCT07511413Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Lung Cancer
Fondazione del Piemonte per l'Oncologia
Observational
110
Candiolo
2024-09-23
Active, closed
GCP-Service International West GmbH
Phase 2
41
Ancona, Bari, Candiolo, Florence, Milan, Reggio Calabria
2024-09-10
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Active, closed
Exelixis
Phase 2/3
600
Candiolo, Brescia, Catania, Milan, Naples, Rome, Rozzano, Verona
2024-06-07
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
200
Candiolo
2024-04-30
Recruiting
Daiichi Sankyo
Phase 1/2
680
Candiolo, Milan, Naples, Rome, Rozzano
2024-04-10
Active, closed
Byondis B.V.
Phase 1
17
Brescia, Candiolo, Milan, Ravenna
2024-03-04
Active, closed
Genmab
Phase 3
1,095
Rozzano, Candiolo, Bologna, Catania, Palermo, Reggio Emilia, Roma
2024-02-05
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bologna, Candiolo, Catania, Lecce, Meldola, Messina, Milan, Naples
2024-02-05
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Pesaro, Novara, Candiolo, Milan, Perugia, Roma
2024-02-01
Recruiting
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
NCT07469709Breast Cancer, Colo-rectal Cancer, Ovarian Cancer, Melanoma (Skin Cancer)
Fondazione del Piemonte per l'Oncologia
Observational
850
Candiolo
2024-02-01
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Ancona, Candiolo, Meldola, Milan, Naples, Parma, Pisa, Rozzano
2023-12-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Recruiting
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
NCT06281210Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer, Neoadjuvant Chemotherapy
European Institute of Oncology
Not applicable
77
Candiolo, Milan
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Recruiting
Amgen
Phase 3
750
Bari, Brescia, Candiolo, Catania, Florence, Meldola (FC), Milan, Monza (MB)
2023-11-16
Recruiting
LeonaBio
Phase 3
600
Ancona, Aviano, Candiolo, Meldola, Milan, Misterbianco, Modena, Naples
2023-10-31
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06026410Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
DrugsAdagrasib·Cabozantinib
Kura Oncology, Inc.
Phase 1
300
Bologna, Candiolo, Naples, Rozzano, Verona
2023-10-18
Active, closed
PharmaMar
Phase 3
469
Rozzano, Naples, Aviano, Bologna, Candiolo, Orbassano, Padova, Palermo
2023-09-21
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Candiolo, Milan
2023-09-05
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
NCT05983432Non Small Cell Lung Cancer, Esophageal Cancer, Small Cell Lung Cancer, Nasopharyngeal Cancer
DrugIza-bren
SystImmune Inc.
Phase 1
540
Candiolo, Rozzano
2023-08-08
Recruiting
Consorzio Oncotech
Phase 2
118
Brescia, Candiolo, Catania, Cremona, Florence, Genova, Milan, Modena
2023-04-18
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
36
Candiolo
2023-04-12
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
DrugsELVN-002·Fam-Trastuzumab Deruxtecan-Nxki·Trastuzumab emtansine·Trastuzumab deruxtecan
Enliven Therapeutics
Phase 1
198
Monza, Candiolo, Aviano, Ancona, Roma, Rozzano
2023-03-20
Recruiting
Fondazione del Piemonte per l'Oncologia
Observational
400
Candiolo, Orbassano
2023-03-09
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Active, closed
Pfizer
Phase 1/2
37
Rome, Candiolo
2023-02-23
Recruiting
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
NCT05492682Melanoma (Skin), Triple-Negative Breast Cancer, Non-Small Cell Lung Cancer, Synovial Sarcoma
DrugsCyclophosphamide·Pembrolizumab
Valo Therapeutics Oy
Phase 1
15
Candiolo, Milan, Naples
2023-02-02
Active, closed
Daiichi Sankyo
Phase 3
1,170
Candiolo, Lucca, Orbassano, Rome, Udine, Varese, Verona
2023-01-11
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ancona, Bergamo, Bologna, Brindisi, Candiolo, Florence, Genova, Milan
2022-10-04
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Ancona, Candiolo, Meldola, Messina, Milan, Modena, Monza, Naples
2022-08-31
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
San Giovanni Rotondo, Meldola, Reggio Emilia, Milan, Candiolo, Pisa, Terni, Verona
2022-08-08
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Candiolo, Milan, Naples, Rome, Siena
2022-08-03
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Recruiting
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944Head and Neck Carcinoma
Italian Head&Neck Society
Observational
7,000
Candiolo, Florence, Lecce, Milan, Pavia, Roma, Verona
2022-07-06
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
120
Candiolo, Orbassano
2022-06-29
Active, closed
AstraZeneca
Phase 1/2
174
Candiolo, Milan, Orbassano, Padova
2022-06-02
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Candiolo, Florence
2022-05-18
Active, closed
IO Biotech
Phase 3
407
Ancona, Aviano, Bari, Candiolo, Genova, Meldola, Milan, Naples
2022-05-17
Recruiting
UNICANCER
Phase 3
300
Bari, Candiolo, Foggia, Meldola, Milan, Naples, Roma, Rozzano
2022-04-19
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Aviano, Bologna, Brescia, Candiolo, Florence, Meldola, Milan, Palermo
2022-04-14
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bologna, Candiolo, Genova, Meldola, Milan, Modena, Reggio Emilia, Rome
2021-12-02
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
605
Meldola, Legnano, Sassuolo, Monza, Aviano, Pagani, Candiolo, Castelfranco Veneto
2021-12-01
Recruiting
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
NCT04383119Leiomyosarcoma of Ovary, Soft Tissue Sarcoma
DrugsTrabectedin·Gemcitabine
Italian Sarcoma Group
Phase 2
100
Bologna, Meldola, Prato, Rozzano, Aviano, Roma, Candiolo, Orbassano
2021-10-29
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
Bologna, Candiolo, Florence, Meldola, Milan, Naples, Padova, Prato
2021-10-18
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bologna, Candiolo, Milan, Palermo, Prato, Roma
2021-09-23
Recruiting
Italian Sarcoma Group
Phase 2
16
Prato, Roma, Candiolo, Bologna, Milan, Palermo
2021-09-14
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Recruiting
Fondazione del Piemonte per l'Oncologia
Observational
100
Candiolo
2021-07-01
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Avellino, Biella, Cagliari, Candiolo, Lido di Camaiore, Meldola, Milan, Naples
2021-06-24
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893Ewing Sarcoma of Bone
Italian Sarcoma Group
Observational
100
Rozzano, Aviano, Candiolo, Bari, Bologna, Florence, Genova, Milan
2021-06-01
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
DrugsImzokitug·Pumitamig·Docetaxel·Nivolumab
Bristol-Myers Squibb
Phase 1/2
1,109
Rozzano, Candiolo, Milan, Naples, Roma, Siena
2021-05-27
Active, closed
Daiichi Sankyo
Phase 3
490
Barone, Candiolo, Catanzaro, Milan, Modena, Naples, Padua, Pisa
2021-05-21
Active, closed
Incyte Corporation
Phase 3
899
Bergamo, Brescia, Candiolo, Catania, Forlì, Genoa, Lecce, Milan
2021-05-11
Active, closed
AstraZeneca
Phase 3
1,157
Bergamo, Candiolo, Genova, Livorno, Milan, Naples, Padova, Rozzano
2021-04-26
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Recruiting
Italian Sarcoma Group
Observational
300
Bologna, Milan, Rozzano, Palermo, Aviano, Prato, Roma, Candiolo
2021-04-02
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Aviano, Candiolo, Meldola, Milan, Padova, Roma
2021-01-20
Active, closed
Pfizer
Phase 3
257
Udine, Milan, San Sisto, Roma, Rome, Siena, Candiolo, Bari
2021-01-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
Pfizer
Phase 3
841
Monserrato (CA), San Giovanni Rotondo, Milan, Candiolo, Orbassano, Brescia, Naples, Padova
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Arezzo, Candiolo, Carpi, Catania, Foggia, Genova, Lugo, Milan
2020-12-07
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Active, closed
Genmab
Phase 1/2
543
Bergamo, Bologna, Candiolo, Meldola, Milan, Pavia, Reggio Emilia
2020-11-03
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Rome, Milan, Rozzano, Candiolo, Naples
2020-10-29
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
500
Genova, Milan, Padua, Pisa, Candiolo, Orbassano, Torino
2020-10-28
Active, closed
Hoffmann-La Roche
Phase 3
992
Meldola, Rome, Brescia, Milan, Monza, Misterbianco (CT), Candiolo, Livorno
2020-10-09
Active, closed
AstraZeneca
Phase 3
370
Brescia, Candiolo, Florence, Milan, Modena, Naples, Padova
2020-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Arezzo, Candiolo, Cremona, Lecce, Meldola, Milan, Naples, Orbassano
2020-09-23
Active, closed
Philogen S.p.A.
Phase 2
98
Bologna, Candiolo, Orbassano, Roma
2020-08-28
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
AstraZeneca
Phase 3
866
Aviano, Bergamo, Candiolo, Cona, Genova, Livorno, Messina, Milan
2020-07-24
Recruiting
University of Turin, Italy
Not applicable
416
Grosseto, Sesto San Giovanni, La Spezia, Candiolo, Pinerolo, Bologna, Ferrara, Genova
2020-07-13
Active, closed
AstraZeneca
Phase 3
818
Bergamo, Candiolo, Catanzaro, Livorno, Meldola, Milan, Modena, Naples
2020-04-16
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Areezo, Candiolo, Cremona, Genova, Meldola, Milan, Pisa, Terni
2020-03-30
Recruiting
Eli Lilly and Company
Phase 2
105
Bologna, Candiolo, Milan, Padova, Roma, Rozzano
2020-01-22
Active, closed
Nouscom SRL
Phase 1/2
115
Avellino, Candiolo, Milan, Siena
2019-10-21
Recruiting
ALFAOMEGA Master Observational Trial
NCT04120935Colorectal Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
3,000
Biella, Milan, Padova, Perugia, Pisa, Ravenna, Candiolo, Orbassano
2019-10-15
Active, closed
Fondazione del Piemonte per l'Oncologia
Not applicable
30
Candiolo
2019-09-26
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Meldola, Rozzano, Roma, Bari, Bergamo, Candiolo, Catania, Genova
2019-08-09
Active, closed
Tesaro, Inc.
Phase 3
785
Candiolo, Carpi MO, Lecce, Milan, Naples, Ponderano BI, Rome, Sassuolo
2019-07-18
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Rozzano, Candiolo, Cremona, Lombardia, Milan, Toscana, Veneto
2019-03-15
Recruiting
Inhibrx Biosciences, Inc
Phase 1
411
Candiolo, Milan
2018-10-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Bologna, Rome, Milan, Monza, Rozzano, Aviano, Catania, Candiolo
2018-08-21
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Alessandria, Bologna, Candiolo, Meldola, Milan
2018-06-26
Active, closed
pharmaand GmbH
Phase 3
1,097
Aviano, Candiolo, Catania, Chieti, Naples, Roma, Vicenza
2018-05-14
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Bergamo, Candiolo, Carpi, Catania, Ferrara, Lecco, Livorno, Milan
2018-04-05
Recruiting
An Observational Study on Epithelioid Sarcoma
NCT03099681Epithelioid Sarcoma
Italian Sarcoma Group
Observational
100
Meldola, Milan, Rozzano, Palermo, Candiolo, Bologna, Padova, Prato
2017-08-22
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Recruiting
Observational Study on Endometrial Stromal Tumors
NCT02829437Endometrial Stromal Tumors
Italian Sarcoma Group
Observational
100
Meldola, Milan, Palermo, Aviano, Padova, Candiolo, Bologna, Florence
2016-10
Active, closed
Eli Lilly and Company
Phase 3
493
Brindisi, Cona, Genoa, Candiolo, Prato, Negrar, Bergamo, Bologna
2014-11-06
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
DrugTrabectedin
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Rozzano, Aviano, Bologna, Candiolo, Milan
2014-11
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
128
Milan, Ravenna, Candiolo, Castelfranco Veneto, Terni, Busto Arsizio, Alessandria, Ascoli Piceno
2014-05
Recruiting
Italian Network MDS Registry
NCT02808858Myelodysplastic-Myeloproliferative Diseases
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
10,000
Alessandria, Ancona, Genova, Parma, Rionero in Vulture, Candiolo, Torino, Asti
2013-09
Active, closed
MedImmune LLC
Phase 2
571
Alessandria, Aviano, Bergamo, Bologna, Candiolo, Genova, Meldola, Milan
2013-05-17
Active, closed
Fondazione del Piemonte per l'Oncologia
Observational
2,500
Aosta, Bologna, Candiolo, Genova, Milan, Orbassano, Padova, Pisa
2011-03-30
Rows per page Showing 1–158 of 158
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/candiolo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 158 of those studies with a site in Candiolo.

How many clinical trials are recruiting in Candiolo?

92 of the 158 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 62 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Candiolo), 158 studies
PhaseStudiesRecruitingShare
Phase 3672842.4%
Observational231914.6%
Phase 1/2201212.7%
Phase 217710.8%
Not applicable13118.2%
Phase 11086.3%
Phase 2/3653.8%
Phase 4221.3%

Most active sponsors

Lead sponsors with the most studies (Candiolo)
Lead sponsorStudiesRecruiting
Fondazione del Piemonte per l'Oncologia1714
AstraZeneca101
Fondazione Italiana Linfomi - ETS82
Italian Sarcoma Group88
Bristol-Myers Squibb65
Genmab61
Incyte Corporation52
Janssen Research & Development, LLC52
Merck Sharp & Dohme LLC53
Pfizer51
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.